Completed PHASE2 INTERVENTIONAL 2-arm NCT00312481

MOVIPREP® Versus PICOLAX® Pilot Study

A Randomised, Single-Centre, Parallel-Group, Pilot Study to Assess the Efficacy, Safety and Patient Acceptability of a New 2-Litre Bowel Preparation Agent (MOVIPREP®) Compared With a Standard Bowel Preparation Agent (PICOLAX®)

Sponsor: Norgine

Conditions Colonoscopy

Interventions NA picosulfate magnesium citrate macrogol3350 NA sulphate NACL KCL ascorbic acid NA ascorbate

Updated 5 times since 2017 Last updated: Dec 12, 2007 Started: Jul 31, 2005 Completion: May 31, 2006

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE2 clinical study on Colonoscopy, this trial is completed. The trial is conducted by Norgine and has accumulated 5 data snapshots since 2005. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE2
Jul 2024 — Sep 2024 [monthly]

Completed PHASE2
Jan 2021 — Jul 2024 [monthly]

Completed PHASE2
Jun 2018 — Jan 2021 [monthly]

Completed PHASE2
Jan 2017 — Jun 2018 [monthly]

Completed PHASE2

First recorded

Jul 2005

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Norgine

Data source: Norgine

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Oxford, United Kingdom